- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01637701
Plasmakinetic Enucleation of the Prostate to Treat Benign Prostatic Hypertrophy Patients With Large Prostate
July 7, 2012 updated by: Fuzhou General Hospital
Comparison of Pasmakinetic Enucleation of the Prostate With Bipolar Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Hypertrophy Patients With Large Prostate
The goal of this study is to compare the perioperative and postoperative characters of plasmakinetic enucleation of the prostate(PkEP) with bipolar TURP(B-TURP) for BPH patients with large prostate.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Despite the availability of numerous minimally invasive alternatives, monopolar transurethral resection of the prostate (TURP) remains the most frequently performed operation for benign prostatic hypertrophy (BPH) with small to moderate size prostates.
Nevertheless, TURP for large prostates is associated with various complications and unsatisfactory long-term results.
B-TURP and PkEP have both been proved to have more favorable postoperative outcomes than monopolar TURP.
But whether B-TURP or PkEP is better remain controversial.
We aim to compare the perioperative and postoperative characters of PkEP with B-TURP for BPH patients with large prostate.
Moreover, we evaluate the long-term results of both approaches.
Study Type
Interventional
Enrollment (Actual)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Fujian
-
Fuzhou, Fujian, China
- Fuzhou General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Qmax < 10 mL/s, IPSS >19
- Age between 50 and 70 years
- Prostate volume between 70 and 200 mL, as determined by TRUS, and medical therapy failure.
Exclusion Criteria:
- Patients with neurogenic bladder
- Urethral stricture
- Bladder tumor
- Prostate cancer and previous prostate bladder neck
- Urethral surgery
- PSA>4ng/ml, or receiving prostate biopsy within 3 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: PkEP
Patients in this group undergo PkEP using the Gyrus plasmakinetic tissue management system (Gyrus Medical Ltd,Bucks,UK).
|
Plasmakinetic enucleation of the prostate
|
Active Comparator: B-TURP
Patients in this group undergo B-TURP using the Gyrus plasmakinetic tissue management system (Gyrus Medical Ltd,Bucks,UK).
|
Bipolar transurethral resection of the prostate
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
---|---|
time of catheterization
|
At the end of both procedures, a 22F three-way Folley catheter was inserted and continuous bladder irrigation was performed.
Irrigation was discontinued when the catheter drainage became clear, and the catheter was removed 6 h later.Two experienced urologists who were unaware of the surgical modality used decided bladder irrigation and catheter removal for all cases.
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Operation time
|
|
resected adenoma weight as a measure of treatment efficacy
|
|
changes in serum haemoglobin as a measure of one of the complications
|
|
postoperative International Prostate Symptom Score as a measure of treatment efficacy and durability
Time Frame: 5 years
|
5 years
|
postoperative Qmax as a masure of treatment efficacy and durability
Time Frame: 5 years
|
5 years
|
re-operation rate as a measure of durability
Time Frame: 5 years
|
5 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Jianming Tan, M.D. & Ph.D., Fuzhou General Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2004
Primary Completion (Actual)
December 1, 2006
Study Completion (Actual)
December 1, 2011
Study Registration Dates
First Submitted
July 4, 2012
First Submitted That Met QC Criteria
July 7, 2012
First Posted (Estimate)
July 11, 2012
Study Record Updates
Last Update Posted (Estimate)
July 11, 2012
Last Update Submitted That Met QC Criteria
July 7, 2012
Last Verified
July 1, 2012
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PkEP-TURP-2004
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on BPH With Large Prostate
-
Boston Scientific CorporationTerminatedBPH | BPH With Urinary Obstruction | BPH With Urinary Obstruction With Other Lower Urinary Tract SymptomsUnited States, Australia
-
I.M. Sechenov First Moscow State Medical UniversityEnrolling by invitationBPH | Prostate ObstructionRussian Federation
-
Mansoura UniversityRecruiting
-
Benaroya Research InstituteVirginia Mason Hospital/Medical CenterUnknownPain | BPH With Urinary Obstruction | BPH With Urinary Obstruction With Other Lower Urinary Tract SymptomsUnited States
-
Robert W. Alexander, MD, FICSTerry, Glenn C., M.D.WithdrawnNocturia | BPH | BPH With Urinary Obstruction | Prostatism | Prostate InflammationUnited States
-
Mansoura UniversityRecruitingNocturnal Polyurea in Patients With BPHEgypt
-
Mansoura UniversityUnknownProstatic Hyperplasia | Prostate Disease | BPH With Urinary Obstruction | Prostate Obstruction | Ejaculation AbnormalEgypt
-
Cairo UniversityTheodor Bilharz Research InstituteCompletedMale | BPH With Urinary ObstructionEgypt
-
Cairo UniversityCompletedMale | BPH With Urinary ObstructionEgypt
-
BE Technologies IncUrology of VirginiaCompletedOveractive Bladder | Lower Urinary Tract Symptoms | Urinary Incontinence, Urge | Overactive Bladder Syndrome | BPH | Urinary Obstruction | BPH With Urinary Obstruction With Other Lower Urinary Tract Symptoms | BPH Without Urinary Obstruction | BPH Without Urinary Obstruction With Other Lower Urinary...United States
Clinical Trials on PkEP
-
Fuzhou General HospitalCompletedBenign Prostate HyperplasiaChina